Sroczynski, G., Hillemanns, P., & Siebert, U. (2019). PCN43 NEW CERVICAL CANCER SCREENING POLICY IN GERMANY - WHAT IS THE IMPACT ON THE BENEFIT-HARM BALANCE? Value in Health, 22, S443. https://doi.org/10.1016/j.jval.2019.09.240
Chicago Style (17th ed.) CitationSroczynski, G., P. Hillemanns, and U. Siebert. "PCN43 NEW CERVICAL CANCER SCREENING POLICY IN GERMANY - WHAT IS THE IMPACT ON THE BENEFIT-HARM BALANCE?" Value in Health 22 (2019): S443. https://doi.org/10.1016/j.jval.2019.09.240.
MLA (9th ed.) CitationSroczynski, G., et al. "PCN43 NEW CERVICAL CANCER SCREENING POLICY IN GERMANY - WHAT IS THE IMPACT ON THE BENEFIT-HARM BALANCE?" Value in Health, vol. 22, 2019, p. S443, https://doi.org/10.1016/j.jval.2019.09.240.
Warning: These citations may not always be 100% accurate.